CL2007003806A1 - Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer. - Google Patents

Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer.

Info

Publication number
CL2007003806A1
CL2007003806A1 CL2007003806A CL2007003806A CL2007003806A1 CL 2007003806 A1 CL2007003806 A1 CL 2007003806A1 CL 2007003806 A CL2007003806 A CL 2007003806A CL 2007003806 A CL2007003806 A CL 2007003806A CL 2007003806 A1 CL2007003806 A1 CL 2007003806A1
Authority
CL
Chile
Prior art keywords
compounds
cancer
treatment
pyrazol
amide
Prior art date
Application number
CL2007003806A
Other languages
Spanish (es)
Inventor
Andrew Peter Thomas
David Buttar
Kevin Michael Foote
Maria Elena Theoclitou
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68342344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003806(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CL2007003806A1 publication Critical patent/CL2007003806A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPUESTO DE FÓRMULA I, O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DE ÉL. TAMBIÉN SE HAN PROVISTO PROCESOS PARA LA PRODUCCIÓN DE UN COMPUESTO DE LA FÓRMULA I Y EL USO DE UN COMPUESTO DE LA FÓRMULA I COMO UN MEDICAMENTO Y EN EL TRATAMIENTO DEL CÁNCER.COMPOSED OF FORMULA I, OR A PHARMACEUTICALLY ACCEPTABLE SALT OF IT. PROCESSES HAVE ALSO BEEN PROVIDED FOR THE PRODUCTION OF A COMPOUND OF FORMULA I AND THE USE OF A COMPOUND OF FORMULA I AS A MEDICINAL PRODUCT AND IN THE TREATMENT OF CANCER.

CL2007003806A 2007-11-05 2007-12-21 Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer. CL2007003806A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98554207P 2007-11-05 2007-11-05
US87119007P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
CL2007003806A1 true CL2007003806A1 (en) 2009-05-08

Family

ID=68342344

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007003806A CL2007003806A1 (en) 2007-11-05 2007-12-21 Compounds derived from n- (2h-pyrazol-3-yl) -amide, fgfr inhibitors; pharmaceutical composition comprising said compounds; its preparation process; and its use for the treatment of cancer.

Country Status (1)

Country Link
CL (1) CL2007003806A1 (en)

Similar Documents

Publication Publication Date Title
UY30819A1 (en) DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
ECSP12011799A (en) ESPIROPIPERIDINE AND PHARMACEUTICAL USE OF THE SAME COMPOUNDS
UY31918A (en) FGFR INHIBITING PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES FOR THE PREPARATION AND USE AS A MEDICINAL PRODUCT
DK2324008T3 (en) Diarylpyrazole as protein kinase inhibitors
ECSP12011930A (en) NEW SPYROPIPERIDINE COMPOUNDS
ECSP109934A (en) COMPOUND - 946
UY31215A1 (en) PIRIMIDINE MORPHOLINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY.
CL2007001435A1 (en) Phenylalanine derivative compounds; preparation process; pharmaceutical composition comprising said compound; and use of the compound as integrin inhibitors for the treatment of cancer.
UY30444A1 (en) PIRIMIDINE DERIVATIVES, PROCESSES FOR PREPARATION, PHARMACCUTIC COMPOSITIONS AND USES OF THE SAME.
CO6251364A2 (en) DERIVATIVES OF MORFOLINO PIRIMIDINA USED IN DISEASES RELATED TO MTOR QUINASA AND / OR P13K
UY30472A1 (en) NEW PIRIMIDINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESSES FOR THEIR PREPARATION AND APPLICATIONS.
UY30759A1 (en) CHEMICAL COMPOUNDS
UY30559A1 (en) DERIVATIVES OF MORFOLINO PIRIMIDINA, PREPARATION PROCESSES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
PE20151005A1 (en) COATED PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
CO6290656A2 (en) UREA HETEROCICLICAL DERIVATIVES AND METHODS OF USE OF THE SAME -211
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
AR069508A1 (en) DERIVATIVES OF QUINOLINA 057; A PROCESS FOR PREPARATION; A PHARMACEUTICAL COMPOSITION; THE PREPARATION OF THIS AND THE USE OF THE COMPOUND TO PREPARE A MEDICINAL PRODUCT
MX2009013501A (en) Piperidine compounds and uses thereof.
CO6480931A2 (en) HETEROCYCLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
UY32674A (en) UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS
CL2007000781A1 (en) NANOPARTICLES THAT INCLUDE A THYROSINE KINASE INHIBITOR RECEIVING THE GROWTH FACTOR DERIVED FROM PLATES; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF VASCULAR DISEASES, SUCH AS RESTENOSIS
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
CR20130693A (en) TYPICAL ORTALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB
EA200870223A1 (en) DERIVATIVES OF BENZOIZOINDOL FOR THE TREATMENT OF PAIN
CL2007003220A1 (en) COMPOUNDS DERIVED FROM 4-PHENYLAMINO-QUINOLINO-3-CARBOXAMIDA, INHIBITORS OF CSF-1R QUINASA; PREPARATION PROCESS; INTERMEDIATE COMPOUNDS INVOLVED IN THIS PROCESS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF CHEST TUMORS, PR